Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-06-01

FDA Approved: AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE — Original Application (Strides Pharma Science Limited)

View source ↗

Summary

FDA approved Strides Pharma Science Limited's original ANDA for a fixed-dose combination of amlodipine besylate, valsartan, and hydrochlorothiazide as a generic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMLODIPINE BESYLATE VALSARTAN HYDROCHLOROTHIAZIDE (amlodipine besylate; valsartan; hydrochlorothiazide)

Snippet

ORIG AP for AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE (AMLODIPINE BESYLATE VALSARTAN HYDROCHLOROTHIAZIDE)